Valantine Hannah 4

What Happened
Valantine Hannah, a director of Pacific Biosciences of California, Inc. (PACB), received a derivative award on 2026-06-03 covering 223,492 shares at a reported price of $0.00. This was an award/grant (derivative security), not a sale or market purchase—no cash changed hands in the filing.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-04 (timely filing).
• Transaction type/code: A — grant/award of a derivative security.
• Shares/units granted: 223,492; reported price: $0.00.
• Shares owned after transaction: not specified in the filing.
• Footnote: The award vests monthly over one year (on the same day of the month as grant) or, if earlier, at the next annual stockholders’ meeting, provided she continues to serve as a director (per footnote F1).

Context

• This is a compensation-related award (common for directors) rather than a buy or sale; such grants are often routine and intended to align directors with shareholder interests.
• Because this is a derivative award (not an exercised option or immediate sale), there was no immediate change in market-held shares; vesting conditions determine when Hannah can convert or receive shares.